Advanced treatments, known as immunotherapies that activate T cells—our body's immune cells—to eliminate cancer cells, have shown limited efficacy...
Vous n'êtes pas connecté
Researchers at the Garvan Institute of Medical Research have identified a potential new therapeutic target for pancreatic cancer, one of the most lethal cancer types with limited treatment options.
Advanced treatments, known as immunotherapies that activate T cells—our body's immune cells—to eliminate cancer cells, have shown limited efficacy...
Advanced treatments, known as immunotherapies that activate T cells—our body's immune cells—to eliminate cancer cells, have shown limited efficacy...
Gliomas are among the deadliest brain tumors, with limited treatment options and poor survival rates. Scientists from China identified FAM111B, a...
A multinational team of researchers, co-led by the Garvan Institute of Medical Research, has developed and tested a new AI tool to better characterize...
A team of international researchers led by scientists in the USA provides the most thorough account yet of an elusive target for cancer treatment....
A team of international researchers led by scientists in the USA provides the most thorough account yet of an elusive target for cancer treatment....
A team of researchers from the San Raffaele-Telethon Institute for Gene Therapy (SR-TIGET, Milan), led by Nadia Coltella and Luigi Naldini, has...
West Australian researchers have made a breakthrough medical discovery in the fight against a rare genetic muscle disorder.
West Australian researchers have made a breakthrough medical discovery in the fight against a rare genetic muscle disorder.
Colorectal cancer (CRC) is the second most common cause of death from cancer in the United States (US) and the most prevalent malignant tumor...